$EOLS
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Healthcare
Sector
Drug Manufacturers - Specialty & Generic
Industry
David Moatazedi
CEO
372
Employees
$4.64
Current Price
$432.35M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 4 | $796,936.19 | 163,504 | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 4 | $796,936.19 | 163,504 | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 4 | $796,936.19 | 163,504 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 4 | $796,936.19 | 163,504 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 4 | $796,936.19 | 163,504 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 20, 2026 | Avelar Rui See Remarks | Sale | 3,119 | $4.75 | $14,815.25 | View Details |
| Mar 20, 2026 | MOATAZEDI DAVID Director | Sale | 13,669 | $4.75 | $64,929.12 | View Details |
| Mar 17, 2026 | MOATAZEDI DAVID Director | Sale | 116,720 | $4.89 | $570,562.38 | View Details |
| Mar 17, 2026 | Avelar Rui Chief Medical Officer and Head of Research & Development | Sale | 29,996 | $4.89 | $146,629.45 | View Details |
| Dec 22, 2025 | MOATAZEDI DAVID Director | Sale | 10,539 | $7.15 | $75,361.23 | View Details |
| Dec 22, 2025 | Avelar Rui Chief Medical Officer & Head of Research and Development | Sale | 2,261 | $7.15 | $16,167.73 | View Details |
9 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
EPS
EstimatedN/A
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Past Earnings
Historical earnings results
EPS
Estimated$0.06
ActualN/A
Revenue
EstimatedN/A
ActualN/A
3 more earnings records available โ create a free account to see 12 months of history
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: